Confluent Medical Technologies Inc, Scottsdale, Ariz., is expanding its supply agreement with Allegheny Technologies (ATI) related to the manufacture and supply of ELI Nitinol, a specialized metal alloy used primarily to produce high-performance minimally invasive medical devices and components.
Confluent will provide funding to increase the furnace capacity at ATI Specialty Alloys and Components to produce ELI Nitinol at ATI’s Albany, Oregon site by 33%. Confluent has full access to production volumes through 2026.
“Expanding our strategic partnership with ATI is an important investment for Confluent,” said Dean Schauer, president, and CEO of Confluent. “This investment significantly increases the available supply of ELI Nitinol material, which is in high demand for the most critical medical device applications.
“Securing additional melt capacity for this unique, high-purity, high-fatigue-resistant material allows us to meet the increasing demand for current customers, while also expanding availability for new offerings of medical device products and components,” said Schauer.
Confluent Medical Technologies
